106 related articles for article (PubMed ID: 15132971)
21. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.
Rosenberg A; Mathew P
Expert Opin Investig Drugs; 2013 Jun; 22(6):787-94. PubMed ID: 23540855
[TBL] [Abstract][Full Text] [Related]
22. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
23. LRP: role in vascular wall integrity and protection from atherosclerosis.
Boucher P; Gotthardt M; Li WP; Anderson RG; Herz J
Science; 2003 Apr; 300(5617):329-32. PubMed ID: 12690199
[TBL] [Abstract][Full Text] [Related]
24. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
[TBL] [Abstract][Full Text] [Related]
25. [Blockade of the PDGF receptor: a new and effective therapy option for NPM-ALK-dependent lymphoma].
Laimer-Gruber D
Pathologe; 2014 Nov; 35 Suppl 2():185-6. PubMed ID: 25352000
[No Abstract] [Full Text] [Related]
26. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease.
Zoja C; Corna D; Rottoli D; Zanchi C; Abbate M; Remuzzi G
Kidney Int; 2006 Jul; 70(1):97-103. PubMed ID: 16688113
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
[TBL] [Abstract][Full Text] [Related]
28. Effective treatment of hypereosinophilic syndrome with imatinib mesylate.
Salem Z; Zalloua PA; Chehal A; Bitar N; Abboud M; Kadri A; Chami B; Bazarbachi A
Hematol J; 2003; 4(6):410-2. PubMed ID: 14671612
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
[TBL] [Abstract][Full Text] [Related]
30. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
31. [Experience with imatinib to treat pulmonary arterial hypertension].
García Hernández FJ; Castillo Palma MJ; González León R; Garrido Rasco R; Ocaña Medina C; Sánchez Román J
Arch Bronconeumol; 2008 Dec; 44(12):689-91. PubMed ID: 19091239
[TBL] [Abstract][Full Text] [Related]
32. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
[TBL] [Abstract][Full Text] [Related]
33. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension.
Patterson KC; Weissmann A; Ahmadi T; Farber HW
Ann Intern Med; 2006 Jul; 145(2):152-3. PubMed ID: 16847299
[No Abstract] [Full Text] [Related]
34. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
Sumida T; Kitadai Y; Shinagawa K; Tanaka M; Kodama M; Ohnishi M; Ohara E; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2011 May; 128(9):2050-62. PubMed ID: 21387285
[TBL] [Abstract][Full Text] [Related]
35. Molecule of the Month. PDGFR-alpha antagonist Gleevec reduces blood vessel leakage and increases the therapeutic window associated with tissue plasminogen activator stroke treatment.
Lewis JA
Curr Top Med Chem; 2008; 8(15):1416-7. PubMed ID: 19006853
[No Abstract] [Full Text] [Related]
36. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
Capdeville R; Buchdunger E; Zimmermann J; Matter A
Nat Rev Drug Discov; 2002 Jul; 1(7):493-502. PubMed ID: 12120256
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
[TBL] [Abstract][Full Text] [Related]
38. FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis.
Gilliland G; Cools J; Stover EH; Wlodarska I; Marynen P
Hematol J; 2004; 5 Suppl 3():S133-7. PubMed ID: 15190295
[No Abstract] [Full Text] [Related]
39. PDGF receptor and its antagonists: role in treatment of PAH.
Grimminger F; Schermuly RT
Adv Exp Med Biol; 2010; 661():435-46. PubMed ID: 20204747
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]